Clinical Trial Update: An Immunogenicity and Safety Study of Tetanus, Diphtheria and Acellular Pertussis Vaccine Booster [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the immunogenicity and safety of a tetanus, diphtheria and acellular pertussis vaccine booster.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Pertussis
• Tetanus

Drugs mentioned

• Tetanus, Diphtheria and Acellular Pertussis Vaccine Booster (Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis booster)

Snippet

Sponsor: Swedish Institute for Infectious Disease Control | Conditions: Tetanus, Diphtheria | Phase 4 | Status: UNKNOWN